Drug Type Prophylactic vaccine |
Synonyms 9valent Escherichia coli vaccine Janssen + [3] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Urinary Tract Infections | Phase 3 | NL | 30 Jun 2021 | |
Urinary Tract Infections | Phase 3 | FR | 30 Jun 2021 | |
Urinary Tract Infections | Phase 3 | DK | 30 Jun 2021 | |
Urinary Tract Infections | Phase 3 | CO | 30 Jun 2021 | |
Urinary Tract Infections | Phase 3 | DE | 30 Jun 2021 | |
Urinary Tract Infections | Phase 3 | SE | 30 Jun 2021 | |
Urinary Tract Infections | Phase 3 | CA | 30 Jun 2021 | |
Urinary Tract Infections | Phase 3 | NZ | 30 Jun 2021 | |
Urinary Tract Infections | Phase 3 | JP | 30 Jun 2021 | |
Enteroinvasive Escherichia Coli Infection | Phase 3 | US | - |